GLOW Blend 70mg
LOT MOL-106
>99.50%
HPLC purity · meets spec
- Labeled
- 50 / 10 / 10mg
- Measured
- 51.52 / 10.05 / 9.94mg
- Identity
- GHK-Cu · BPC-157 · TB-500
- Tested
- Aug 7, 2026
5 assays passed · ISO/IEC 17025 accredited
View certificate
GLOW Blend | 50mg/10mg/10mg Peptide Vials
$130.00
Regular price
$195.00
Sale price
$130.00
Skip to product information
GLOW Blend | 50mg/10mg/10mg Peptide Vials
$130.00
Regular price
$195.00
Sale price
$130.00
Type
Bundle & save
Price
$130.00
For research use only. Not for human consumption. Compassionate curators of fine peptides.
GHK-Cu / BPC-157 / TB-500 · 50mg/10mg/10mg
Mollecule GLOW Blend (GHK-Cu/BPC-157/TB-500) combines three of today's most recognized research peptides into one carefully formulated peptide blend. Designed for advanced research applications, this formulation brings together compounds that continue to generate significant scientific interest across multiple areas of peptide biology. Like every Mollecule product, the GLOW Blend is manufactured under strict quality controls, independently third-party tested, and accompanied by a Certificate of Analysis (COA) verifying purity and batch consistency.
Pack
50mg/10mg/10mg Peptide Vials: $130.00
Also available: GLOW Blend | 5ct Peptide Strips
Related peptides
Third-party verified
Certificate of Analysis
Every lot is HPLC-tested at an ISO/IEC 17025-accredited lab. Open any batch’s certificate below.
Sources & References
Peer-reviewed research
-
NEW ENGLAND JOURNAL OF MEDICINE
Triple-Hormone-Receptor Agonist GLP-3 (RT) for Obesity - A Phase 2 Trial
View Source -
THE LANCET
GLP-3 (RT) for People with Type 2 Diabetes - A Phase 2 Trial
View Source -
NATURE MEDICINE
GLP-3 (RT) for Metabolic Dysfunction-Associated Steatotic Liver Disease
View Source -
LANCET DIABETES & ENDOCRINOLOGY
Effects of GLP-3 (RT) on Body Composition
View Source -
PUBMED CENTRAL
Triple Agonism Based Therapies for Obesity
View Source -
PUBMED CENTRAL
GLP-3 (RT) - A Game Changer in Obesity Pharmacotherapy
View Source -
PUBMED CENTRAL
Efficacy and Safety of GLP-3 (RT) - Systematic Review & Meta-Analysis
View Source -
NATURE CELL DISCOVERY
Structural Analysis of Incretin Receptor Agonists
View Source